Catalyst Event
Pacific Biosciences of California Inc (PACB) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/7/2026, 12:00:00 AM
First quarter 2026 financial results are scheduled to be released on 2026-05-07. Analysts forecast EPS of approximately -$0.17 and revenue of around $39.98 million. Estimated price impact is Medium (5-10%) as earnings reports are key volatility drivers for this stock. scheduled
Korean Translation
2026년 5월 7일 2026년 1분기 재무 결과 발표 예정임. 분석가들은 주당 순이익(EPS) 약 -0.17달러, 매출 약 3998만 달러로 예상함. 실적 발표는 통상 5-10%의 주가 변동을 유발하므로 중요도를 'Medium'으로 추정함. 예정됨
Related Recent Events
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date for the final dividend of RMB 1.43 per share for the fiscal year 2025 on 2026-06-16, scheduled.
6/16/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
Annual General Meeting to be held on 2026-05-21 to review reports and approve plans; routine meetings typically have a 1-5% price impact, scheduled
5/21/2026, 12:00:00 AM
Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Other
An earnings briefing for the 2025 fiscal year and Q1 2026 results is scheduled for May 14, 2026. This routine communication event is estimated to have a price impact of at least 1% scheduled.
5/14/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
Caris Life Sciences to report first quarter 2026 financial results on May 7, 2026, scheduled.
5/7/2026, 12:00:00 AM
Guardant Health Inc (GH) · Earnings Release
Guardant Health is scheduled to release its Q1 2026 financial results after market close on May 7, 2026. Analysts forecast EPS of ($0.47) and revenue of $279.17 million. High importance estimated due to potential for significant volatility following earnings results, scheduled.
5/7/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is scheduled to release its first quarter 2026 financial results after the market closes on May 7, 2026, with analysts forecasting revenue of approximately $617.5 million and an EPS of -$0.55; high importance is expected due to typical earnings volatility, scheduled.
5/7/2026, 12:00:00 AM